HIF-1α Is an Essential Mediator of IFN-γ-Dependent Immunity to Mycobacterium tuberculosis

Journal of Immunology

Volumn 197, Issue 4, 2016, Pages 1287-1297

  Braverman, Jonathan ^a   Sogi, Kimberly M ^a   Benjamin, Daniel ^b   Nomura, Daniel K ^b   Stanley, Sarah A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ICOSANOID; NITRIC OXIDE; RNA; HIF1A PROTEIN, MOUSE;

AEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SEQUENCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOLYSIS; IMMUNOLOGY; KNOCKOUT MOUSE; LIQUID CHROMATOGRAPHY; PHYSIOLOGICAL FEEDBACK; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUBERCULOSIS; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEEDBACK, PHYSIOLOGICAL; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TUBERCULOSIS;

EID: 84983772191     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600266     Document Type: Article

References (43)

1. Floyd, K. 2012. Global Tuberculosis Report 2012, World Health Organization. WHO Press, Geneva, Switzerland.
2. Abel, L., and J.-L. Casanova. 2000. Genetic predisposition to clinical tuberculosis: bridging the gap between simple and complex inheritance. Am. J. Hum. Genet. 67: 274-277.
3. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
4. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon gamma genedisrupted mice. J. Exp. Med. 178: 2243-2247.
5. Zhang, Y. J., M. C. Reddy, T. R. Ioerger, A. C. Rothchild, V. Dartois, B. M. Schuster, A. Trauner, D. Wallis, S. Galaviz, C. Huttenhower, et al. 2013. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing. Cell 155: 1296-1308.
6. Alonso, S., K. Pethe, D. G. Russell, and G. E. Purdy. 2007. Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Natl. Acad. Sci. USA 104: 6031-6036.
7. Fabri, M., S. Stenger, D. M. Shin, J. M. Yuk, P. T. Liu, S. Realegeno, H. M. Lee, S. R. Krutzik, M. Schenk, P. A. Sieling, et al. 2011. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 3: 104.
8. Gutierrez, M. G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
9. MacMicking, J. D., G. A. Taylor, and J. D. McKinney. 2003. Immune control of tuberculosis by IFN-gamma-inducible LRG-47. Science 302: 654-659.
10. Kim, B. H., A. R. Shenoy, P. Kumar, R. Das, S. Tiwari, and J. D. MacMicking. 2011. A family of IFN-g-inducible 65-kD GTPases protects against bacterial infection. Science 332: 717-721.
11. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175: 1111-1122.
12. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94: 5243-5248.
13. Tannahill, G. M., A. M. Curtis, J. Adamik, E. M. Palsson-McDermott, A. F. McGettrick, G. Goel, C. Frezza, N. J. Bernard, B. Kelly, N. H. Foley, et al. 2013. Succinate is an inflammatory signal that induces IL-1b through HIF-1a. Nature 496: 238-242.
14. Shalova, I. N., J. Y. Lim, M. Chittezhath, A. S. Zinkernagel, F. Beasley, E. Hernández-Jiménez, V. Toledano, C. Cubillos-Zapata, A. Rapisarda, J. Chen, et al. 2015. Human monocytes undergo functional re-programming during sepsis mediated by hypoxia-inducible factor-1a. Immunity 42: 484-498.
15. Peyssonnaux, C., V. Datta, T. Cramer, A. Doedens, E. A. Theodorakis, R. L. Gallo, N. Hurtado-Ziola, V. Nizet, and R. S. Johnson. 2005. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115: 1806-1815.
16. Lin, A. E., F. C. Beasley, J. Olson, N. Keller, R. A. Shalwitz, T. J. Hannan, S. J. Hultgren, and V. Nizet. 2015. Role of hypoxia inducible factor-1a (HIF-1a) in innate defense against uropathogenic Escherichia coli infection. PLoS Pathog. 11: E1004818.
17. Berger, E. A., S. A. McClellan, K. S. Vistisen, and L. D. Hazlett. 2013. HIF-1a is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitis. PLoS Pathog. 9: E1003457.
18. Cramer, T., Y. Yamanishi, B. E. Clausen, I. Fö rster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, et al. 2003. HIF-1a is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
19. Elks, P. M., S. Brizee, M. van der Vaart, S. R. Walmsley, F. J. van Eeden, S. A. Renshaw, and A. H. Meijer. 2013. Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism. PLoS Pathog. 9: E1003789.
20. Cardoso, M. S., T. M. Silva, M. Resende, R. Appelberg, and M. Borges. 2015. Lack of the transcription factor hypoxia-inducible factor 1a (HIF-1a) in macrophages accelerates the necrosis of Mycobacterium avium-induced granulomas. Infect. Immun. 83: 3534-3544.
21. Anders, S., P. T. Pyl, and W. Huber. 2015. HTSeq: A Python framework to work with high-throughput sequencing data. Bioinformatics 31: 166-169.
22. Benjamin, D. I., A. Cozzo, X. Ji, L. S. Roberts, S. M. Louie, M. M. Mulvihill, K. Luo, and D. K. Nomura. 2013. Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity. Proc. Natl. Acad. Sci. USA 110: 14912-14917.
23. Lee, J. W., S. H. Bae, J. W. Jeong, S. H. Kim, and K. W. Kim. 2004. Hypoxiainducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36: 1-12.
24. Mishra, B. B., V. A. Rathinam, G. W. Martens, A. J. Martinot, H. Kornfeld, K. A. Fitzgerald, and C. M. Sassetti. 2013. Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1b. Nat. Immunol. 14: 52-60.
25. Eigenbrod, T., K. A. Bode, and A. H. Dalpke. 2013. Early inhibition of IL-1b expression by IFN-g is mediated by impaired binding of NF-kB to the IL-1b promoter but is independent of nitric oxide. J. Immunol. 190: 6533-6541.
26. Mayer-Barber, K. D., B. B. Andrade, S. D. Oland, E. P. Amaral, D. L. Barber, J. Gonzales, S. C. Derrick, R. Shi, N. P. Kumar, W. Wei, et al. 2014. Hostdirected therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511: 99-103.
27. Divangahi, M., D. Desjardins, C. Nunes-Alves, H. G. Remold, and S. M. Behar. 2010. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 11: 751-758.
28. Chen, M., M. Divangahi, H. Gan, D. S. Shin, S. Hong, D. M. Lee, C. N. Serhan, S. M. Behar, and H. G. Remold. 2008. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205: 2791-2801.
29. Divangahi, M., M. Chen, H. Gan, D. Desjardins, T. T. Hickman, D. M. Lee, S. Fortune, S. M. Behar, and H. G. Remold. 2009. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10: 899-906.
30. Tobin, D. M., J. C. Vary Jr., J. P. Ray, G. S. Walsh, S. J. Dunstan, N. D. Bang, D. A. Hagge, S. Khadge, M. C. King, T. R. Hawn, et al. 2010. The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140: 717-730.
31. Tobin, D. M., F. J. Roca, S. F. Oh, R. McFarland, T. W. Vickery, J. P. Ray, D. C. Ko, Y. Zou, N. D. Bang, T. T. Chau, et al. 2012. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148: 434-446.
32. Jung, F., L. A. Palmer, N. Zhou, and R. A. Johns. 2000. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86: 319-325.
33. Kopp, F., T. Komatsu, D. K. Nomura, S. A. Trauger, J. R. Thomas, G. Siuzdak, G. M. Simon, and B. F. Cravatt. 2010. The glycerophospho metabolome and its influence on amino acid homeostasis revealed by brain metabolomics of GDE1 (-/-) mice. Chem. Biol. 17: 831-840.
34. Colegio, O. R., N. Q. Chu, A. L. Szabo, T. Chu, A. M. Rhebergen, V. Jairam, N. Cyrus, C. E. Brokowski, S. C. Eisenbarth, G. M. Phillips, et al. 2014. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513: 559-563.
35. Singh, V., S. Jamwal, R. Jain, P. Verma, R. Gokhale, and K. V. Rao. 2012. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 12: 669-681.
36. Mehrotra, P., S. V. Jamwal, N. Saquib, N. Sinha, Z. Siddiqui, V. Manivel, S. Chatterjee, and K. V. Rao. 2014. Pathogenicity of Mycobacterium tuberculosis is expressed by regulating metabolic thresholds of the host macrophage. PLoS Pathog. 10: E1004265.
37. Rossignol, R., R. Gilkerson, R. Aggeler, K. Yamagata, S. J. Remington, and R. A. Capaldi. 2004. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64: 985-993.
38. Chang, C. H., J. D. Curtis, L. B. Maggi Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. van der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.
39. Nandi, B., and S. M. Behar. 2011. Regulation of neutrophils by interferon-g limits lung inflammation during tuberculosis infection. J. Exp. Med. 208: 2251- 2262.
40. Via, L. E., P. L. Lin, S. M. Ray, J. Carrillo, S. S. Allen, S. Y. Eum, K. Taylor, E. Klein, U. Manjunatha, J. Gonzales, et al. 2008. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76: 2333- 2340.
41. Aly, S., K. Wagner, C. Keller, S. Malm, A. Malzan, S. Brandau, F. C. Bange, and S. Ehlers. 2006. Oxygen status of lung granulomas in Mycobacterium tuberculosis- infected mice. J. Pathol. 210: 298-305.
42. Klinkenberg, L. G., L. A. Sutherland, W. R. Bishai, and P. C. Karakousis. 2008. Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J. Infect. Dis. 198: 275-283.
43. Su, X., Y. Yu, Y. Zhong, E. G. Giannopoulou, X. Hu, H. Liu, J. R. Cross, G. Rätsch, C. M. Rice, and L. B. Ivashkiv. 2015. Interferon-g regulates cellular metabolism and mRNA translation to potentiate macrophage activation. Nat. Immunol. 16: 838-849.